CASC3 and neoplasm: Consistent with in vivo models, OS cells showed increased survival in response to BTZ when endogenous ATF4 was silenced; however, ATF4 overexpression alone not only suppressed the proliferation of tumor cells but also sensitized the cells to BTZ-induced growth arrest.